The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
FDA staffers tell CR how the suspension of their discretionary spending is threatening the safety of the American food supply ...
A federal report found the FDA is struggling to meet inspection targets at high-risk facilities. We look at why these checks ...
Shilpa Medicare has announced that the United States Food and Drug Administration (USFDA) conducted an inspection at Unit-2 of its subsidiary, Shilpa Pharma Lifesciences, located in Raichur, with zero ...
If drug tariffs don’t work, they could result in higher prices for American patients and increase drug shortages. Testing ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
The Food and Drug Administration is investigating a new outbreak of infections caused by Listeria monocytogenes. There are 28 ...
Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company's Active Pharmaceutical Ingredient (API) Unit 1, located in ...
A California company’s dried lily flowers have been recalled because they may contain undeclared sulfites, according to the U ...